Discure Technologies vs Immunai

Discure Technologies vs Immunai, compared side by side on 22 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Discure Technologies is on 50/100 and Immunai on 69/100.

Discure Technologies logo
Discure TechnologiesDevelops minimally invasive bioelectronic solutions for treating low back pain and spinal degeneration.
Try Discure Technologies
Immunai logo
ImmunaiMapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.
Try Immunai

Where each one leads

Discure Technologies

  • agent readiness: 37/100 against 32/100
  • headcount growth: +18.4% against +13.0%

Immunai

  • our overall score: 69/100 against 50/100
  • domain rating: 46/100 against 4/100
  • headcount: 179 against 12
  • funding raised: $295M against $11.0M
  • LinkedIn following: 26,832 against 1,859

At a glance

MeasureDiscure TechnologiesImmunai
What it isDevelops minimally invasive bioelectronic solutions for treating low back pain and spinal degeneration.Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.
CategoryHealthcare, Patient Care, Life Sciences, Medical DevicesHealthcare, Immunology, Data, Analytics
Sells toBusiness modelB2BB2B
OfferingHardwareSoftware
Founded20212019
HeadquartersTel Aviv, IsraelNew York, United States
StatusActiveActive

Size, funding and growth

MeasureDiscure TechnologiesImmunai
Employees12179
Headcount growthLast 12 months+18.4%+13.0%
Total funding$11.0M$295M
Latest roundSeries ASeries B
ValuationNot published$1.0B
LinkedIn followers1,85926,832

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasureDiscure TechnologiesImmunai
StartupHub scoreOur 0-100 rating50/10069/100
Traction46/10060/100
Team30/10070/100
Search visibility30/10039/100
Quality58/10078/100
Agent readinessHow well an AI agent can read and act on the siteF (37/100)F (32/100)
Domain ratingLink authority, 0-1004/10046/100

Technology

Detected on each public site, so it reflects the marketing stack as well as the product.

MeasureDiscure TechnologiesImmunai
HostingSelf ManagedNot detected
CMSWordPressWordPress
FrameworksJquery, BootstrapJquery, Bootstrap
AnalyticsGoogle Analytics 4Google Tag Manager

Discure Technologies vs Immunai: common questions

Which is better, Discure Technologies or Immunai?

On our 0-100 score Immunai rates higher (69/100 against 50/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 22 data points above: read the rows that match what you are buying for.

How do Discure Technologies and Immunai compare on the numbers?

Discure Technologies leads on agent readiness (37/100 against 32/100), headcount growth (+18.4% against +13.0%). Immunai leads on our overall score (69/100 against 50/100), domain rating (46/100 against 4/100), headcount (179 against 12), funding raised ($295M against $11.0M), LinkedIn following (26,832 against 1,859).

Read the full Discure Technologies review and pricing or the Immunai review and pricing. You can also browse other Discure Technologies alternatives we track.